Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1050
Oncology Information System Market (OIS) is estimated to value over CAGR of over 7% during the forecast period 2022 to 2028. Oncology information system (OIS) is used to manage the data of cancer patient treatment programmes, treatments plans, treatment deliveries, treatment summaries and diagnostic results. The OIS will encircle the information exchange with other departments within the health care enterprise and it must be connected to other hospitals information system. It will assist in the evaluation and improvement of therapy from information on cancer stage and treatment. OIS accredits improved medical safety and professional effectiveness. There are various resources like paper-based (hospital registries), network etc., which will help to maintain oncology information at healthcare enterprise. The increasing demand for IT services due to increasing prevalence is expected to fuel the growth of oncology information systems market. It is advantageous over traditional methods of data handling & validations and it further decreased the manual effort and automated the process. Along with this, the oncology information system has huge applicability in healthcare settings for better management of cancer patients. Further, changing healthcare policies to encourage smart technologies led to robust growth of oncology information systems market. Additionally, it improves patient care and helps in better management of cancer patients. All these factors led to significant growth of burgeoning growth of oncology information systems market Global Oncology information system market is dominated by North America and Europe due to high penetration and well-established healthcare systems. Further, they are expected to remain dominant throughout the forecast period. The Asia Pacific is expected to create a lot of opportunities for manufacturers due to the high patient population. Latin America and Rest of World Oncology information systems market are expected to witness slow growth over the forecast period due to slow adoption. Oncology Information Systems market is expected to witness new players during the forecast period due to the increasing importance of information systems in data management. Market players include: Accuray Incorporated, Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical Systems, Inc. Oncology Information System Market Segmentation: By Application Surgical Oncology Radiation Oncology Medical Oncology By Products and Services Software Patient Information Systems Treatment Planning Systems Professional Services Consulting/Optimization Services Implementation Services Post-sale & Maintenance Services By End User Hospitals Diagnostic Laboratories Outpatient Centres Clinics By Region Europe North America APAC Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on global oncology information system market by application, products and services type, end-user and region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Oncology information system (OIS) is used to manage the data of cancer patient treatment programmes, treatments plans, treatment deliveries, treatment summaries and diagnostic results. The OIS will encircle the information exchange with other departments within the health care enterprise and it must be connected to other hospitals information system. It will assist in the evaluation and improvement of therapy from information on cancer stage and treatment. OIS accredits improved medical safety and professional effectiveness. There are various resources like paper-based (hospital registries), network etc., which will help to maintain oncology information at healthcare enterprise.
The increasing demand for IT services due to increasing prevalence is expected to fuel the growth of oncology information systems market. It is advantageous over traditional methods of data handling & validations and it further decreased the manual effort and automated the process. Along with this, the oncology information system has huge applicability in healthcare settings for better management of cancer patients. Further, changing healthcare policies to encourage smart technologies led to robust growth of oncology information systems market. Additionally, it improves patient care and helps in better management of cancer patients. All these factors led to significant growth of burgeoning growth of oncology information systems market
Global Oncology information system market is dominated by North America and Europe due to high penetration and well-established healthcare systems. Further, they are expected to remain dominant throughout the forecast period. The Asia Pacific is expected to create a lot of opportunities for manufacturers due to the high patient population. Latin America and Rest of World Oncology information systems market are expected to witness slow growth over the forecast period due to slow adoption.
Oncology Information Systems market is expected to witness new players during the forecast period due to the increasing importance of information systems in data management.
Market players include:
Accuray Incorporated, Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical Systems, Inc. Oncology Information System Market Segmentation:
By Application
By Products and Services
By End User
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Oncology Information System Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Oncology Information System Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Oncology Information System Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Oncology Information System Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Oncology Information System Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 7.1 Surgical Oncology 7.2 Radiation Oncology 7.3 Medical Oncology 8. Global Oncology Information System Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Software 8.1.1. Patient Information Systems 8.1.2. Treatment Planning Systems 8.2. Professional Services 8.2.1. Consulting/Optimization Services 8.2.2. Implementation Services 8.2.3. Post-sale & Maintenance Services 9. Global Oncology Information System Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Diagnostic Laboratories 9.3. Outpatient Centres 9.4. Clinics 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Accuray Incorporated 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Bogardus Medical Systems, Inc. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Cerner Corporation 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. CureMD Corporation 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Elekta AB 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Flatiron Health, Inc. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Koninklijke Philips N.V. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. McKesson Corporation 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. RaySearch Laboratories AB 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Varian Medical Systems, Inc. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics